On March 4, Guangzheng Ophthalmology released a news that in 2024, the company will accelerate the divestiture of non-medical business as much as possible, and related matters are being promoted, but they have not yet reached the discloseable standard, and will be disclosed in the statutory information disclosure channel after reaching it.
This is enough to show that in the future, Guangzheng Ophthalmology will "divest its original main business and further focus on the medical business".
With the intensive introduction of the state's policy of encouraging social medical services, not only Guangzheng Ophthalmology, but also many enterprises engaged in real estate and retail business in recent years are divesting their original industries and choosing to fully enter the medical and health market.
It is reported that in 2015, Yihua Real Estate, a listed real estate company, began to transform into the medical and health industry, and changed the name of the listed company from "Yihua Real Estate" to "Yihua Health". In 2016, Yihua Health completely divested its real estate business through first-class assets and the transfer of equity in subsidiaries, transforming from a real estate developer to a medical and health enterprise. Since then, Yihua Health has bought Jiangyin Baiyi Traditional Chinese Medicine Hospital, Kunshan Changhai Hospital, Hangzhou Sanatorium & Hospital, Hangzhou Ciyang Elderly Hospital and many other hospitals.
In May 2021, Jiangsu Aoyang Health, a listed company, announced a major asset ** plan, disclosing that Aoyang Health intends to 17400 million ** chemical fiber business, comprehensive transformation of medical and health business. It is understood that the predecessor of Aoyang Health is Aoyang Technology, and its main business is the production and sales of viscose staple fiber. Before announcing the divestment of the chemical fiber business, Aoyang Health has formed a layout with Aoyang Hospital as the main hospital, Gangcheng ** Hospital, Aoyang Nursing Home, Health Management Company, Sanxing Branch of Aoyang Hospital, and Aoyang Shunkang Hospital as the linkage, with a total of more than 2,000 beds.
In June and October 2021, the A-share listed company "Yonghe Intelligent Control" issued two consecutive announcements on the progress of major asset restructuring and related party transactions, announcing its withdrawal from the fluid intelligent control business and focusing on the medical and health industry, which is expected to be no less than 4The transaction capital of 300 million yuan was invested in the medical industry. Previously, Yonghe Intelligent Control had acquired Dazhou Medical Cancer Hospital and Kunming Medical Cancer Hospital, and also participated in Xi'an Medical Cancer Hospital and established Chongqing Huapu Cancer Hospital.
It can be seen that the capital market's favor for the private medical track can be seen.